UNILAG Don, Prof. Abdul Kareem Co-Leads Nigeria’s First Immunotherapy Clinical Theory for Colorectal Cancer at LUTH

UNILAG Don, Prof. Abdul Kareem Co-Leads Nigeria’s First Immunotherapy Clinical Theory for Colorectal Cancer at LUTH

UNILAG Don, Prof. Abdul Kareem Co-Leads Nigeria’s First Immunotherapy Clinical Theory for Colorectal Cancer at LUTH

The Lagos University Teaching Hospital (LUTH), in collaboration with MedServe Cancer Center has launched Nigeria’s first immunotherapy clinical trial for colorectal cancer, marking a major milestone in the country’s cancer research and treatment landscape.

RECOMMENDED FOR YOU: KWASU Vice-Chancellor Appoints Dr. Babatunde as Acting Director of ICT Experience Centre

Dean of the Faculty of Basic Clinical Sciences, College of Medicine, University of Lagos (CMUL), Professor Fatimah AbdulKareem is the Principal Investigator of the study while Dr. Eben Aje of MedServe Cancer Center is the Co-Principal Investigator and Project Director.

RECOMMENDED FOR YOU: TETFund Boosts Innovation with N7.5bn Research Funding Across Nigerian Tertiary Institutions